Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells

26 Sept 2017

Abstract excerpt

Neuroblastoma is the most common solid extra cranial tumor in infants. Improving the clinical outcome of children with aggressive tumors undergoing one of the multiple treatment options has been a major concern. Differentiating neuroblastoma cells holds promise in inducing tumor growth arrest and treating minimal residual disease. In this study, we investigated the effect of partial PPARγ agonist 2-cyano-3,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mitochondrial Function and Pathology
Share to Neuroblastoma Research and Treatments
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29018329
DOI: 10.3389/fnmol.2017.00310

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma CellsPMID 29018329Read ↗

Sub-micromolar concentrations of retinoic acid induce morphological and functional neuronal phenotypes in SK-N-SH neuroblastoma cells.Semantic proximity Read ↗

Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid.Semantic proximity Read ↗

Palbociclib releases the latent differentiation capacity of neuroblastoma cellsSemantic proximity Read ↗

Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic DifferentiationSemantic proximity Read ↗

PBX1 Is a Favorable Prognostic Biomarker as It Modulates 13- <i>cis</i> Retinoic Acid–Mediated Differentiation in NeuroblastomaSemantic proximity Read ↗

N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53.Semantic proximity Read ↗

PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsSemantic proximity Read ↗

Cell death-based treatment of neuroblastomaSemantic proximity Read ↗

Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiationSemantic proximity Read ↗

Metabolic characteristics of 13‐cis‐retinoic acid (isotretinoin) and anti‐tumour activity of the 13‐cis‐retinoic acid metabolite 4‐oxo‐13‐cis‐retinoic acid in neuroblastomaSemantic proximity Read ↗

IRE1α is critical for kaempferol induced neuroblastoma differentiationSemantic proximity Read ↗

Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.